Heather Holt

Heather Holt is a global clinical project and program manager with over 15 years of experience in leading Phase I-IV trials focused on rare diseases, cell therapy, and oncology. Currently, Heather serves as a Senior Global Trial Leader and Program Manager at CSL, specializing in clinical portfolio execution in gene therapy and rare disease. Heather has previously held key roles at organizations such as Syneos Health and Pfizer, where notable achievements include securing FDA approval for a global COVID-19 vaccine project. With a strong foundation in regulatory compliance and patient-centered innovation, Heather's work emphasizes cross-functional collaboration and advocacy engagement. Education includes a Bachelor of Science in Health Care Administration from Purdue University.